Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Non-Small-Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06946797
What this trial is testing

Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 76
Early research (Phase 1)Study completedNCT01562210
What this trial is testing

Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC

Who this might be right for
NSCLC
The Netherlands Cancer Institute 28
Not applicableNot Yet RecruitingNCT07631520
What this trial is testing

Intelligent Pulmonary Rehabilitation After Lung Cancer Surgery

Who this might be right for
Non-Small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 200
Testing effectiveness (Phase 2)Ended earlyNCT02095782
What this trial is testing

Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation

Who this might be right for
Non-small-cell Lung Cancer
Guangdong Association of Clinical Trials 10
Testing effectiveness (Phase 2)Looking for participantsNCT06706076
What this trial is testing

BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
BlossomHill Therapeutics 675
Testing effectiveness (Phase 2)Looking for participantsNCT06222489
What this trial is testing

Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT

Who this might be right for
Non-Small Cell Lung CarcinomaAdvanced Non-Small Cell Squamous Lung CancerEGFR Gene Mutation
The Netherlands Cancer Institute 16
Testing effectiveness (Phase 2)Study completedNCT02697591
What this trial is testing

INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 100
Testing effectiveness (Phase 2)UnknownNCT04167774
What this trial is testing

Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Sun Yat-sen University 62
Testing effectiveness (Phase 2)Looking for participantsNCT07306624
What this trial is testing

Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
STCube, Inc. 62
Testing effectiveness (Phase 2)UnknownNCT03543306
What this trial is testing

Dabrafenib and Trametinib in Patients With Non-small Cell Lung Cancer Harboring V600E BRAF Mutation

Who this might be right for
CancerLung Cancer MetastaticBRAF V600E
Asan Medical Center 27
Early research (Phase 1)UnknownNCT02321293
What this trial is testing

Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC

Who this might be right for
Lung Cancer
Lady Davis Institute 20
Testing effectiveness (Phase 2)Study completedNCT04184921
What this trial is testing

Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

Who this might be right for
Lung Cancer Non-small Cell Stage IV
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 216
Not applicableStudy completedNCT02364804
What this trial is testing

Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shiga University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884
What this trial is testing

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Who this might be right for
Solid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more
Haihua Yuan 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06971406
What this trial is testing

High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

Who this might be right for
Non Small Cell Lung CancerEGFR MutationLeptomeningeal Metastases+1 more
Qiming Wang 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06205706
What this trial is testing

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Solid TumorsNon Small Cell Lung CancerHepatocellular Carcinoma
BioInvent International AB 35
Large-scale testing (Phase 3)Looking for participantsNCT06840704
What this trial is testing

Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer

Who this might be right for
Non Small Cell Lung CancerSmall Cell Lung Cancer
Hunan Cancer Hospital 121
Testing effectiveness (Phase 2)Looking for participantsNCT05713006
What this trial is testing

Alectinib Pharmacokinetic in Patients With NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBALK Gene Mutation
Instituto Nacional de Cancerologia de Mexico 45
Early research (Phase 1)WithdrawnNCT01611584
What this trial is testing

A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer in Normal and Malignant Tumors
Dartmouth-Hitchcock Medical Center
Early research (Phase 1)Study completedNCT00712504
What this trial is testing

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorsNon Small Cell Lung Cancer
Pfizer 49
Next Page